Gelteq Limited Prices US$5.2 Million Initial Public Offering

Quick Summary:

NEW YORK, Oct.28, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited ("Gelteq" or the "Company"), a global biotechnology company that specializes in the formulation, development, and manufacturing of ingestible gel technology, announced today that it has priced its initial public offering of 1,300,000 ordinary shares of the Company at a public offering price of US$4.00 per share.

The Company intends to use the net proceeds from the offering for various purposes, including funding certain manufacturing, marketing and research and development activities.  

The Benchmark Company, LLC is acting as the lead managing underwriter for the offering.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Author / Journalist: Globe Newswire

Category: InvestingBusiness

Markets: United StatesAustralia

Topics: IPOs News Press Releases

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-10-29 @ 01:50:36 (4 days ago)

News Timezone: GMT +8:00

News Source URL: benzinga.com

Language: English

Article Length: 611 words

Reading Time: 4 minutes read

Sentences: 26 lines

Sentence Length: 24 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Benzinga

News ID: 23367557

View Article Analysis

About Benzinga

Main Topics: InvestingBusiness

Official Website: benzinga.com

Year Established: 2010

Headquarters: United States

News Last Updated: 1 days ago

Coverage Areas: United States

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #54

Publisher Details

Frequently Asked Questions